Company Overview and News


Add UNIS
to your dashboard

Headline News

Gifts That Keep On Giving: Is Backdating Back? : TheCorporateCounsel.net Blog

2018-01-03 thecorporatecounsel.net
Last month, the WSJ published an investigative report that suggested that hundreds of corporate insiders frequently had uncanny timing when it came to gifts of company stock. (7-1)

Ampoules and Syringes Market, Plastic Ampoules, Cyclic Olefin Copolymers, and Cyclic Olefin Polymers; Syringe Product Type - Polymer Syringes and Glass Syringes - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

2017-07-10 prnewswire
LONDON, July 10, 2017 /PRNewswire/ -- Global Ampoules and Syringes Market: Overview This report provides forecast and analysis of the ampoules and syringes market on the global and regional level. The study provides historic data of 2015 along with forecast from 2016 to 2024 based on volume (Mn Units) and revenue (US$ Mn). It includes drivers, restraints and the ongoing trend of the ampoules and syringes market along with their impact on demand during the forecast period.

Shutdown Looming: Unilife Files for Chapter 11

2017-04-12 devicespace
KING OF PRUSSIA, Pa., April 12, 2017 /PRNewswire/ -- Unilife Corporation ("Unilife" and together with its domestic subsidiaries, the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that it has commenced a formal proceeding to restructure its balance sheet or to sell its assets as a going concern in order to better position the business for the future.  To facilitate this restructuring or sale, the Company filed voluntary petitions under chapter 11 of the U.

Unilife Files for Chapter 11 Protection

2017-04-12 prnewswire
KING OF PRUSSIA, Pa., April 12, 2017 /PRNewswire/ -- Unilife Corporation ("Unilife" and together with its domestic subsidiaries, the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that it has commenced a formal proceeding to restructure its balance sheet or to sell its assets as a going concern in order to better position the business for the future.  To facilitate this restructuring or sale, the Company filed voluntary petitions under chapter 11 of the U.

The Expectations For West Pharmaceutical Look Hard To Meet

2017-03-17 seekingalpha
West is a strong player in components and delivery systems for injectable pharmaceuticals, a nearly $300 billion market growing at a mid-single digit rate.

Biodel Is A Cash-Poor Risk

2016-11-16 seekingalpha
Biodel has been developing a more effective concentrated insulin, and a much more user-friendly glucagon rescue kit, than commercially available counterparts.

Unilife Provides Business Update

2016-11-03 devicespace
YORK, Pa., Nov. 2, 2016 /PRNewswire/ -- As previously announced, Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) management is hosting a conference call to provide an operational and financial update today at 4:30 p.m. EDT (7:30 a.m. AEDT on Thursday, November 3, 2016).

Unilife Corporation 2016 Q4 - Results - Earnings Call Slides

2016-11-03 seekingalpha
The following slide deck was published by Unilife Corporation in conjunction with their 2016 Q4 earnings call.

Unilife's (UNIS) CEO John Ryan on Q4 2016 Results - Earnings Call Transcript

2016-11-03 seekingalpha
Good day, ladies and gentlemen. And welcome to the Unilife Corporation Fourth Quarter Fiscal 2016 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call maybe recorded.

Unilife Announces Filing of 2016 10-K

2016-10-24 devicespace
YORK, Pa., Oct. 24, 2016 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced that it has filed its Annual Report on Form 10-K for fiscal year 2016. In addition, the Company filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2016 along with (i) an amendment to the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2015; (ii) an amendment to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2015; and (iii) an amendment to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2015.

Unilife shoring up business; shares jump 73%

2016-10-24 seekingalpha
Thinly traded nano cap Unilife (UNIS +73.1%) shows some life in early trading on a healthy 23x surge in volume. This morning it announced that it completed its internal investigation into possible violations of company policies and procedures and possible violations of law and regulations by its former CEO and former Chairman related to certain funds used to purchase a home for the former CEO. No material financial loss to the company was identified.

Unilife Provides Trading Update

2016-09-30 devicespace
YORK, Pa., Sept. 29, 2016 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) announced today that the Company will not be able to file its audited financial statements by September 30, 2016.  As a result, pursuant to rules of the Australian Securities Exchange ("ASX"), trading in the Company's CHESS Depositary Interests ("CDIs") on the ASX will be suspended prior to the opening of trading on the ASX on October 3, 2016, or earlier if ASX accepts the Company's request for an immediate voluntary suspension of trading prior to such date.

Unilife Announces Receipt Of Delinquency Letter From Relating To Fiscal 2016 Form 10-K

2016-09-26 devicespace
YORK, Pa., Sept. 23, 2016 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it has received a letter (the "NASDAQ letter") from The NASDAQ Stock Market LLC ("NASDAQ") notifying the Company that it is not in compliance with NASDAQ Listing Rule 5250(c)(1) because it has not filed its Annual Report on Form 10-K for the period ended June 30, 2016 (the "Form 10-K") in a timely manner with the Securities and Exchange Commission (the "SEC").

Unilife Puts Itself Up For Sale - Is The Stock A Buy Now?

2016-09-20 seekingalpha
After Unilife (NASDAQ:UNIS) announced that it hired Morgan Stanley to perform a strategic review, I decided it was time to once again review the company to see if there was any potential. There have been several new developments to digest, mainly the announcement of the company's new insulin patch called "Imperium", along with two new financing arrangements. The financing arrangements consist of:

CUSIP: 90478E103